Staar surgical co (STAA)
Income statement / Quarterly
Apr'20Jan'20Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Net sales

35,187

38,883

39,055

39,664

32,583

31,186

31,770

33,905

27,093

24,852

23,473

21,936

20,350

22,137

20,052

20,974

19,269

20,858

18,750

18,657

18,858

16,573

18,188

20,048

20,178

18,944

17,106

18,164

18,001

16,466

15,866

15,942

15,509

16,381

15,266

16,269

14,849

13,152

13,639

Cost of sales

10,427

10,059

10,004

9,765

8,403

8,194

7,910

8,678

7,662

7,472

6,624

6,462

5,773

6,259

5,180

6,348

6,276

6,194

5,951

6,296

5,959

7,170

6,319

6,381

6,294

5,968

5,047

5,544

5,347

5,298

4,690

4,897

4,607

4,952

4,816

5,408

5,220

4,892

4,960

Gross profit

24,760

28,824

29,051

29,899

24,180

22,992

23,860

25,227

19,431

17,380

16,849

15,474

14,577

15,878

14,872

14,626

12,993

14,664

12,799

12,361

12,899

9,403

11,869

13,667

13,884

12,976

12,059

12,620

12,654

11,168

11,176

11,045

10,902

11,429

10,450

10,861

9,629

8,260

8,679

Selling, general and administrative expenses:
General and administrative

7,969

7,870

7,098

7,508

6,837

6,233

6,087

6,196

5,771

4,716

4,716

4,685

5,348

3,293

4,985

4,928

8,465

4,853

4,853

4,736

5,162

4,264

3,259

5,368

5,396

4,750

4,140

3,923

3,958

4,207

3,450

3,633

3,860

3,947

3,683

3,905

3,397

3,591

3,268

Marketing and selling

11,028

11,203

12,463

11,682

10,143

9,867

10,620

10,659

7,454

8,035

6,495

7,342

6,530

6,680

7,149

7,181

7,675

5,911

6,284

5,832

5,668

5,689

7,026

7,026

6,138

7,416

5,527

5,659

5,286

5,745

5,507

5,366

4,663

4,628

4,439

4,200

4,459

4,552

4,134

Research and development

6,898

7,409

6,156

6,098

5,635

5,705

5,570

5,346

5,407

5,900

4,594

4,767

4,783

4,650

4,453

4,659

6,906

3,962

3,684

3,536

3,579

3,244

3,137

2,498

3,484

1,972

1,684

1,686

1,366

1,803

1,582

1,513

1,546

1,589

1,454

1,393

1,432

1,309

1,376

Medical device tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40

-

45

45

59

0

0

0

0

-

-

-

-

-

-

Other general and administrative expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12

0

165

168

238

490

613

901

656

728

697

555

597

137

193

133

-

700

Total selling, general and administrative expenses

25,895

26,482

25,717

25,288

22,615

21,805

22,277

22,201

18,632

18,651

15,805

16,794

16,661

-

16,587

16,768

-

-

14,821

14,104

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating income (loss)

-1,135

2,342

3,334

4,611

1,565

1,187

1,583

3,026

799

-1,271

1,044

-1,320

-2,084

1,255

-1,715

-2,142

-10,053

-62

-2,022

-1,743

-1,510

-3,742

-1,553

-1,390

-1,342

-1,251

173

694

1,084

-1,243

-91

-164

278

668

737

1,170

208

-1,192

-799

Other income (expense), net:
Interest income, net

216

192

266

259

271

230

-29

-24

-12

-24

-27

-33

-28

-198

29

29

28

-20

29

33

36

52

35

34

33

8

38

41

83

64

65

67

95

83

134

153

153

152

224

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

49

-

25

7

10

9

7

9

8

35

45

7

7

0

7

7

5

13

7

13

Loss on foreign currency transactions

-468

304

-584

11

-248

-291

52

-520

-77

81

444

380

-86

-160

-29

-416

458

-257

20

180

-892

-200

-628

-134

66

77

226

77

-341

102

191

-249

67

-81

-277

72

372

446

-389

Royalty income

94

111

106

163

171

168

159

149

157

181

141

128

131

111

134

351

22

365

224

106

45

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income, net

1

28

26

1

97

21

40

4

17

41

-19

20

5

2

-68

-38

-44

-44

43

-5

25

-311

51

126

160

-295

130

139

90

212

87

309

214

-31

-42

236

163

89

-53

Loss on early extinguishment of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-267

Total other income (expense), net

-157

635

-186

434

291

128

222

-391

85

279

539

495

22

-73

8

-132

408

34

259

297

-858

-183

-605

-32

202

203

327

183

-299

295

220

0

186

-188

-446

160

395

390

-920

Income (loss) before income taxes

-1,292

2,977

3,148

5,045

1,856

1,315

1,805

2,635

884

-992

1,583

-825

-2,062

1,182

-1,707

-2,274

-9,645

-28

-1,763

-1,446

-2,368

-3,925

-2,158

-1,422

-1,140

-1,048

500

877

785

-948

129

-164

464

480

291

1,330

603

-802

-1,719

Provision (benefit) for income taxes

-1,158

-3,402

760

1,131

489

219

346

805

301

-854

410

146

141

1,349

71

-131

-1,604

814

-11

153

-28

-1,387

548

367

219

-172

-25

599

314

466

219

327

232

370

214

469

303

356

-91

Income (loss) from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,158

-1,628

Net income (loss)

-134

6,379

2,388

3,914

1,367

1,096

1,459

1,830

583

-138

1,173

-971

-2,203

-167

-1,778

-2,143

-8,041

-842

-1,752

-1,599

-2,340

-2,538

-2,706

-1,789

-1,359

-876

525

278

471

-1,414

-90

-491

232

110

77

861

300

-1,158

-1,628

Net income (loss) per share:
Net loss per share - basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.05

-0.20

-0.03

-0.04

-0.04

-0.06

-

-0.07

-0.05

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding - basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,210

39,983

39,766

39,727

39,066

38,481

-

38,369

38,168

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (loss) per share from continuing operations - basic (in dollors per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.03

-0.05

Income (loss) per share from continuing operations - diluted (in dollors per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.03

-0.05

Basic

0.00

0.15

0.05

0.09

0.03

0.04

0.03

0.04

0.01

-0.01

0.03

-0.02

-0.05

-

-0.04

-

-

-

-

-

-

-

-

-

-0.04

-0.02

0.01

0.01

0.01

-0.05

0.00

-0.01

0.01

0.01

0.00

0.02

0.01

-0.03

-0.05

Diluted

0.00

0.14

0.05

0.08

0.03

0.03

0.03

0.04

0.01

-0.01

0.03

-0.02

-0.05

-

-0.04

-

-

-

-

-

-

-

-

-

-0.04

-0.02

0.01

0.01

0.01

-0.05

0.00

-0.01

0.01

0.01

0.00

0.02

0.01

-0.03

-0.05

Weighted average shares outstanding:
Basic

44,953

44,695

44,563

44,479

44,235

44,161

43,054

41,723

41,410

41,224

41,110

40,933

40,749

-

40,486

-

-

-

-

-

-

-

-

-

37,794

37,151

36,750

36,496

36,427

36,392

36,292

36,257

36,071

35,566

35,539

35,443

35,188

34,831

34,790

Diluted

44,953

47,077

46,857

46,733

46,913

47,917

46,025

43,999

43,087

40,230

42,104

40,933

40,749

-

40,486

-

-

-

-

-

-

-

-

-

37,794

39,384

39,284

38,342

37,418

34,043

36,292

36,257

38,420

37,731

36,953

36,439

36,389

34,831

34,790